{"certainAgreement":{"piSponsorEmployee":true},"limitationsAndCaveats":{"description":"2 early deaths caused a concern for safety and resulted in suspension of enrollment in May 2013. After a review of the data, the investigators determined that this regimen had unexpected toxicity \\& the trial was closed to enrollment in June 2013."},"pointOfContact":{"email":"rvij@dom.wustl.edu","organization":"Washington University School of Medicine","phone":"314-454-8304","title":"Ravi Vij, M.D."}}